Intensity Thresholds for Aerobic Exercise-Induced HypoalgesiaNAUGLE, Kelly Marie; NAUGLE, Keith E; FILLINGIM, Roger B et al.Medicine and science in sports and exercise. 2014, Vol 46, Num 4, pp 817-825, issn 0195-9131, 9 p.Article

Histologic Response of Dose-intense Chemotherapy With Preoperative Hypofractionated Radiotherapy for Patients With High-risk Soft Tissue SarcomasRYAN, Christopher W; MONTAG, Anthony G; HOSENPUD, Janet R et al.Cancer. 2008, Vol 112, Num 11, pp 2432-2439, issn 0008-543X, 8 p.Article

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomasMAKI, Robert G; WATHEN, J. Kyle; THALL, Peter F et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2755-2763, issn 0732-183X, 9 p.Article

Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancerIBRAHIM, Nuhad K; SAMUELS, Brian; PAGE, Ray et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 6019-6026, issn 0732-183X, 8 p.Article

Is Hodgkin's disease an infectious disease?WOLF, J; DIEHL, V.Annals of oncology. 1994, Vol 5, pp S105-S111, issn 0923-7534, SUP1Conference Paper

The dorsomedial hypothalamus and the response to stress part renaissance, Part revolutionDIMICCO, Joseph A; SAMUELS, Brian C; ZARETSKAIA, Maria V et al.Pharmacology, biochemistry and behavior. 2002, Vol 71, Num 3, pp 469-480, issn 0091-3057Article

Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangementWILLIAMS, M. E; SWERDLOW, S. H.Annals of oncology. 1994, Vol 5, pp S71-S73, issn 0923-7534, SUP1Conference Paper

Lymphokine receptors: a target for immunotherapy of lymphomasWALDMANN, T. A.Annals of oncology. 1994, Vol 5, pp S13-S17, issn 0923-7534, SUP1Conference Paper

Modern treatment of malignant lymphomas : a multidisciplinary approach ? The Kaplan memorial lectureBONADONNA, G.Annals of oncology. 1994, Vol 5, pp 5-16, issn 0923-7534, SUP2Conference Paper

Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entityKADIN, M. E.Annals of oncology. 1994, Vol 5, pp S25-S30, issn 0923-7534, SUP1Conference Paper

Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemicWEISENBURGER, D. D.Annals of oncology. 1994, Vol 5, pp S19-S24, issn 0923-7534, SUP1Conference Paper

Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhoodMURPHY, S. B.Annals of oncology. 1994, Vol 5, pp S31-S33, issn 0923-7534, SUP1Conference Paper

Early bone marrow transplantation in Hodgkin's diseaseARMITAGE, J. O.Annals of oncology. 1994, Vol 5, pp 161-163, issn 0923-7534, SUP2Conference Paper

Proliferation of Reed-Sternberg cells and variants in Hodgkin's diseaseGUPTA, R. K; LISTER, T. A; BODMER, J. G et al.Annals of oncology. 1994, Vol 5, pp S117-S119, issn 0923-7534, SUP1Conference Paper

Activation of the Orexin I Receptor is a Critical Component of CO₂-Mediated Anxiety and Hypertension but not BradycardiaJOHNSON, Philip L; SAMUELS, Brian C; FITZ, Stephanie D et al.Neuropsychopharmacology (New York, NY). 2012, Vol 37, Num 8, pp 1911-1922, issn 0893-133X, 12 p.Article

Chromosome analysis of non-Hodgkin's lymphomas by fluorescence in situ hybridizationHAMMOND, D. W; HANCOCK, B. W; GOYNS, M. H et al.Annals of oncology. 1994, Vol 5, pp S51-S54, issn 0923-7534, SUP1Conference Paper

Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell linesREED, J. C; KITADA, S; TAKAYAMA, S et al.Annals of oncology. 1994, Vol 5, pp S61-S65, issn 0923-7534, SUP1Conference Paper

Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients : a case-controlled analysis of the EBMT Registry dataLIBERTI, G; PEARCE, R; TAGHIPOUR, G et al.Annals of oncology. 1994, Vol 5, pp 151-153, issn 0923-7534, SUP2Conference Paper

Immunotoxins: is there a clinical value?GOTTSTEIN, C; WINKLER, U; BOHLEN, H et al.Annals of oncology. 1994, Vol 5, pp S97-S103, issn 0923-7534, SUP1Conference Paper

Orexin 1 receptors are a novel target to modulate panic responses and the panic brain networkJOHNSON, Philip L; SAMUELS, Brian C; FITZ, Stephanie D et al.Physiology & behavior. 2012, Vol 107, Num 5, pp 733-742, issn 0031-9384, 10 p.Conference Paper

A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphomaSTRAKA, C; PETTENGELL, R; PIELMEIER, A et al.Annals of oncology. 1994, Vol 5, pp S79-S84, issn 0923-7534, SUP1Conference Paper

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma : high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementMCLAUGHLIN, P; HAGEMEISTER, F. B; SWAN, F et al.Annals of oncology. 1994, Vol 5, pp 73-77, issn 0923-7534, SUP2Conference Paper

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyHAGEMEISTER, F. B; PURUGGANAN, R; PODOLOFF, D. A et al.Annals of oncology. 1994, Vol 5, pp 59-63, issn 0923-7534, SUP2Conference Paper

The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomasJAFFE, E. S; ZARATE-OSORNO, A; KINGMA, D. W et al.Annals of oncology. 1994, Vol 5, pp S7-S11, issn 0923-7534, SUP1Conference Paper

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyZAGONEL, V; BABARE, R; MEROLA, M. C et al.Annals of oncology. 1994, Vol 5, pp 127-132, issn 0923-7534, SUP2Conference Paper